Yahoo Canada Web Search

Search results

  1. Regeneron (NASDAQ: REGN) is a leading biotechnology company using the power of science to bring new medicines to patients in need. Learn more.

  2. Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988.

    1,044.66-12.36 (-1.17%)

    at Tue, Jul 2, 2024, 4:00PM EDT - U.S. markets closed

    After Hours 1,045.00 +0.34 (+0.03%)

    Nasdaq Real Time Price

    • Open 1,054.00
    • High 1,058.17
    • Low 1,030.23
    • Prev. Close 1,057.02
    • 52 Wk. High 1,081.17
    • 52 Wk. Low 688.52
    • P/E 31.25
    • Mkt. Cap 116.47B
  3. Regeneron is a leading science and technology company dedicated to inventing, developing and commercializing life-transforming treatments for serious diseases. Our mission is to use the power of science to bring new medicines to patients… over and over again.

  4. Regeneron is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases.

  5. Regeneron is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, our unique ability to repeatedly translate science into medicine has led to numerous approved treatments and product candidates in development, most of ...

  6. Jul 30, 2021 · Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) updated the Emergency Use Authorization (EUA) for the investigational COVID-19 antibody cocktail REGEN-COV™ (casirivimab and imdevimab). The authorization now includes post-exposure prophylaxis in people at high risk for progression ...

  7. Get the latest Regeneron Pharmaceuticals Inc (REGN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment...

  8. Find the latest Regeneron Pharmaceuticals, Inc. (REGN) stock quote, history, news and other vital information to help you with your stock trading and investing.

  9. Jun 24, 2024 · In the assessment of 12-month price targets, analysts unveil insights for Regeneron Pharmaceuticals, presenting an average target of $1069.69, a high estimate of $1229.00, and a low estimate of ...

  10. Discover real-time Regeneron Pharmaceuticals, Inc. Common Stock (REGN) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with...

  1. People also search for